Exploring preclinical and clinical effectiveness of nanoformulations in the treatment of atopic dermatitis: Safety aspects and patent reviews

Leung, 2013, Clinical guidelines on management of atopic dermatitis in children, J. Pediatr., 18, 96 Kubo, 2012, Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases, J. Clin. Invest., 122, 440, 10.1172/JCI57416 Watsun, 2011, Atopic dermatitis, Allergy Asthma Clin. Immunol., 7, S4, 10.1186/1710-1492-7-S1-S4 Correa, 2012, Management of patients with atopic dermatitis: the role of emollient therapy, Dermatol. Res. Pract., 2, 1, 10.1155/2012/836931 More, 2016, Vesicles as a tool for enhanced topical drug delivery, Asian J. Pharm., 10, 196 Zhang, 2013, Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases, Wiley Interdiscip Rev. Nanomed. Nanobiotechnol., 5, 205, 10.1002/wnan.1211 McPherson, 2016, Current understanding in pathogenesis of atopic dermatitis, Indian J. Dermatol., 61, 649, 10.4103/0019-5154.193674 Hensel, 2015, Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification, BMC Vet. Res., 11, 196, 10.1186/s12917-015-0515-5 Gu, 2001, Evaluation of diagnostic criteria for atopic dermatitis: validity of the criteria of Williams et al. in a hospital-based setting, Br. J. Dermatol., 145, 428, 10.1046/j.1365-2133.2001.04379.x Wasserbauer, 2009, Atopic dermatitis, Am. J. Med., 122, 121, 10.1016/j.amjmed.2008.09.014 Darlenski, 2014, Atopic dermatitis as a systemic disease, Clin. Dermatol., 32, 409, 10.1016/j.clindermatol.2013.11.007 Leung, 2004, New insights into atopic dermatitis, J. Clin. Invest., 113, 651, 10.1172/JCI21060 Krakowski, 2008, Topical therapy in pediatric atopic dermatitis, Semin. Cutaneous Med. Surg., 27, 161, 10.1016/j.sder.2008.04.003 Krakowski, 2008, Management of atopic dermatitis in the pediatric population, Pediatrics, 122, 812, 10.1542/peds.2007-2232 www.hikma.com, Accessed 01.05.15. www.drugs.com, Accessed 01.05.15. Senyigit, 2012, Innovative topical formulations for treatment of dermatitis, Recent Pat. Inflammation Allergy Drug Discovery, 6, 186, 10.2174/187221312802652785 Kigasawa, 2010, Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat, Int. J. Pharm., 383, 157, 10.1016/j.ijpharm.2009.08.036 Emer, 2011, A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis, J. Drugs Dermatol., 1, 1 Tuncay, 2013, Investigation of different emulsion systems for dermal delivery of nicotinamide, Pharm. Dev. Technol., 18, 1417, 10.3109/10837450.2012.734514 Onumah, 2013, Pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference, J. Drug Dermatol., 12, 1145 Feng, 2015, Drug loaded PLGA-mPEG microparticles as treatment for atopic dermatitis-like skin lesions in BALB/c mice model, J. Microencapsulation, 32, 201, 10.3109/02652048.2014.995727 Shershakova, 2016, Anti-inflammatory effect of fullerene C60 in a mice model of atopic dermatitis, J. Nanobiotechnol., 14, 11, 10.1186/s12951-016-0159-z Bangale, 2012, Recent nanotechnological aspects in cosmetics and dermatological preparations, Int. J. Pharm. Pharm. Sci., 4, 88 Feldman, 2014, Principles of topical treatment: advancement in gel vehicle technology, J. Drug Dermatol., 13, 423 Sun, 2015, Application of nano and microparticles on the topical therapy of skin-related immune disorders, Curr. Pharm. Des., 21, 2643, 10.2174/1381612821666150416100516 Korting, 2010, Carriers in the topical treatment of skin disease, vol. 197, 435, 10.1007/978-3-642-00477-3_15 Wiesenthal, 2011, Nanoparticles: small and mighty, Int. J. Dermatol., 50, 247, 10.1111/j.1365-4632.2010.04815.x Patel, 2012, Nanocarriers as novel nose-to-brain targeted drug delivery platforms, Indian J. Novel Drug Delivery, 4, 243 Prakash, 2011, Nanoemulsions for drug delivery through different routes, Res. Biotechnol., 2, 1 Alam, 2013, In vivo study of clobetasol propionate loaded nanomemulsion for topical application in psoriasis and atopic dermatitis, Drug Invent. Today, 5, 8, 10.1016/j.dit.2013.02.001 Joseph, 2013, Advances in brain targeted drug delivery: nanoparticulate systems, J. Pharm. Sci. Technol., 3, 1 Hussain, 2013, Antidermatitis perspective of hydrocortisone as chitosan nanocarriers: an ex vivo and in vivo assessment using an NC/Nga mouse model, J. Pharm. Sci., 102, 1063, 10.1002/jps.23446 Hussain, 2014, Down regulation of immunological mediators in 2, 4-dinotrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone loaded chitosan nanoparticles, Int. J. Nanomed., 9, 5143 Rosado, 2013, Hydrocortisone loaded poly (e-caprolactone) nanoparticles for atopic dermatitis, Pharm. Dev. Technol., 18, 710, 10.3109/10837450.2012.712537 Prelaud, 2013, In vitro effects of CpG Oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs- a pilot study, Veterinary Dermatol., 24, e117, 10.1111/vde.12056 Hussain, 2013, Self-assembled polymeric nanoparticles for percutaneous delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model, Int. J. Pharm., 444, 109, 10.1016/j.ijpharm.2013.01.024 Try, 2016, Size dependent skin penetration of nanoparticles in murine and porcine dermatitis model, Eur. J. Pharm. Biopharm., 100, 101, 10.1016/j.ejpb.2016.01.002 Puglia, 2012, Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals, Expert Opin. Drug Delivery, 9, 429, 10.1517/17425247.2012.666967 Singh, 2011, Safer than safe: lipid nanoparticulate encapsulation of tacrolimus with enhanced targeting and improved safety for atopic dermatitis, J. Biomed. Nanotechol., 7, 40, 10.1166/jbn.2011.1191 Kim, 2009, Topical administration of cyclosporine A in a solid lipid nanoparticle formulation, Pharmazie, 64, 510 Pople, 2010, Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis, Int. J. Pharm., 398, 165, 10.1016/j.ijpharm.2010.07.008 Pople, 2012, Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-Part II. in vivo assessment of dermatopharmacokinetics, biodistribution and efficacy, Int. J. Pharm., 434, 70, 10.1016/j.ijpharm.2012.04.051 Pople, 2011, Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Eur. J. Pharm. Biopharm., 79, 82, 10.1016/j.ejpb.2011.02.016 Pople, 2013, Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus: part-II. In vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis, Eur. J. Pharm. Biopharm., 84, 72, 10.1016/j.ejpb.2012.11.026 Zoschke, 2015, Dendritic nanoparticles for cutaneous drug delivery-testing in human skin and reconstructed human skin, Curr. Pharm. Des., 21, 2784, 10.2174/1381612821666150428142515 Akhtar, 2014, Vesicles: a recently developed novel carrier for enhanced topical drug delivery, Curr. Drug Delivery, 11, 87, 10.2174/15672018113106660064 Goindi, 2013, Development of novel elastic-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis, AAPS PharmSciTech, 14, 1284, 10.1208/s12249-013-0017-3 Goindi, 2014, Ethosomes-based topical delivery system of antihistaminic drug for treatment of skin allergies, J. Microencapsulation, 31, 716, 10.3109/02652048.2014.918667 Jung, 2011, Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy, Pharmazie, 66, 430 Jahn, 2014, AAPE proliposomes for topical atopic dermatitis treatment, J. Microencapsulation, 31, 768, 10.3109/02652048.2014.932027 Lei, 2013, Development of tacrolimus loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo, Asian J. Pharm. Sci., 8, 336, 10.1016/j.ajps.2013.09.005 Goindi, 2014, Novel flexible vesicles based topical formulation of levocetirizine: in vivo evaluation using oxazolone induced atopic dermatitis in murine model, J. Liposome Res., 24, 249, 10.3109/08982104.2014.899365 Li, 2012, Preparation and in vitro evaluation of tacrolimus loaded ethosomes, Sci. World J., 2, 1 Hong, 2012, In vitro skin permeation enhancement of KIOM-MA-128 by monoolein cubosomes, J. Dispersion Sci. Technol., 33, 1503, 10.1080/01932691.2011.620863 www.clinicaltrials.gov, Accessed 02.01.16. N. Warne, C. Bedrosian, J. Keith, U. Schwerschlag, P. Schendel, Topical formulations for delivery of interleukin-11.US 20030147849 A1, 2003. K. Reimer, W. Fleischer, Use of PVP-iodine liposomes for treatment of atopic dermatitis. WO 2004073683 A1, 2004. H.I. Maibach, E.C. Luo, T.M. Hsu, Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses, US 6943197 B2, 2005. R. Lee, D. Shenoy, D. Wright, Nano-structured compositions and methods of making and using the same, US 20070264349 A1, 2007. J. Edelson, T. Kotyla, B. Zhang. Use of nanoemulsion in the manufacture of a medicament for the treating skin disorders, CA 2726836 A1, 2009. S.K. Gupta, Topical delivery system for phytosterols, US 20090042846 A1, 2009. J. Burnier, T. Gadek, Topical LFA-1 antagonists for use in localized treatment of immune related disorders, US 20090258070 A1, 2009. C. Keck, Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles, WO 2010051918 A2, 2010. J. Edelson, T. Kotyla, B. Zhang. Dermal delivery, EP 2310000 A1, 2011. J. Kim, A. Friedman, R. Modlin. Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles, US 20110135742 A1, 2011. J. Chantalat, J.C. Liu, S.A. May, M. Southall, Y. Sun, Topical anti-inflammatory composition, US 20110236491 A1, 2011. G. Liversidge, S. Jenkins, H.W. Bosch, C.F. Wertz, Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof US 8003127 B2, 2011. C.A. Mirkin, A.S. Paller, D.A. Giljohann, Delivery of oligonucleoide-functionalized nanoparticles, EP 2419535 A1, 2012. P.C.N. Neto, D.O.A. Marim , M.I. Re, A.C. Tedesco, Colloidal nanoscale carriers for active hydrophilic substances and method for producing same, EP 2583671 A1, 2013. S. Benita, T. Nasser, N. Karra, A. Badihi, Nanoparticles based for dermal and systemic delivery of drugs, EP 2667844 A2, 2013. E.M. Ostertag, P.C. Tumeh, P.P. Ghoroghchian, Compositions and methods for treating or preventing immuno-inflammatory disease, US 20130202712 A1, 2013. S. Magdassi, L. Larush, C. Mendelson, M. Oron, Z. Maor, I.R. Afriat-Staloff, M. Privorotski, Dispersions in oil of dead sea nano sized material preparation and uses therof, US 20130236571 A1, 2013. J. Edelson, T. Kotyla, K. Theobald, Nanoparticles compositions, formulations thereof and uses therefor, EP 2667859 A2, 2013. M. Sachdeva, P. Shah, Surface modified multilayered nanostructures for dermal delivery, US 8647661 B1, 2014. E. Resnick, L. Resnick, A. Resnick, Topical compositions and methods of use, WO 2014043304 A1, 2014. O.C. Farokhazad, X.Z.X. Xu, N. Kamaly, M.M.P.M. Valencia, R.S. Langer, I. Tabas, G.B. Fredman, Targeted polymeric inflammation-resolving nanoparticles, WO 2014145749 A1, 2014. L.B. Jansen, K. Petersson, A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative, EP 2688560 A2, 2014. M.S. Sachdeva, R. Patlolla, Nanoparticle formulations for skin delivery, US 8715736 B2, 2014. N.V. Perricone, Methods and systems for treatment of inflammatory diseases with nitric oxide, US 9198853 B2, 2015. A. Zemtsov, Formulations and methods for treatment of inflammatory skin diseases, EP 2838509 A1, 2015. F. Granucci, D. Prosperi, I. Zanoni, F.R.M. Corsi, M. Colombo, Nanoconstructs with pharmacological activity, EP 2874663 A1, 2015. P. Sukothai, L.H. Bay. METADICHOL R liquid and gel nanoparticle formulation, CN 105188687 A, 2015. T.J. Harris, A.A.C. Kim, Targeted delivery of nanoparticles to skin surface, WO 2015031189 A1, 2015. H. Katas, A.M.C.I. Mohd, S. Sahudin, F. Buang, Chitosan-based skin-targeted nanoparticle drug delivery system and method, WO 2015072846 A1, 2015. K.M. Demock, C.P. Donahue, R.L. Hale, J.L.J. Nelson, P.S. Pendergrast, Aptamers for topical delivery, WO 2015140722 A1, 2015. A. Schwendeman, M. Cohen, C. Subramanian, R. Kuai, D. Li, P. White, J. Moon, Compositions and methods for disease treatment using nanoparticle delivered compounds, WO 2016011049 A3, 2016. Kumar, 2014, Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation, Nanoscale, 5, 8307, 10.1039/c3nr01525d Hirai, 2012, Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection, Part. Fibre Toxicol., 9, 22, 10.1186/1743-8977-9-3 Gupta, 2013, Nanocarriers and nanoparticles fro skin care and dermatological treatments, Indian Dermatol. Online J., 4, 267, 10.4103/2229-5178.120635 Keck, 2014, A new concept for the treatment of atopic dermatitis: silver-nanolipid complex (sNLC), Int. J. Pharm., 462, 44, 10.1016/j.ijpharm.2013.12.044 Silva, 2006, Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis, J. Eur. Acad. Dermatol. Venereol., 20, 1114, 10.1111/j.1468-3083.2006.01748.x